BACKGROUND: Cell-cycle checkpoint controls regulate cell-cycle progression and proliferation. Alterations in cell-cycle control mechanisms are linked to tumorigenesis. METHODS: This case-control study included 147 cases and 147 controls. The authors used a pathway-based approach to assess the association between 10 potential functional single-nucleotide polymorphisms from 7 cell-cycle control genes and the risk of oral premalignant lesions (OPLs). They also used classification and regression tree analysis to examine high-order gene-gene and gene-smoking interactions. RESULTS: Compared with the homozygous wild-type GG genotype of CCND1 P241P, individuals with the AG genotype exhibited an increased risk of OPL (odds ratio, 1.58; 95% confidence interval, 0.89-2.83), and carriers of the AA genotype had a significantly increased risk of OPL (odds ratio, 2.75; 95% confidence interval, 1.33-5.71), with risk increasing significantly with the increasing number of variant alleles (P= .006). The risk of OPL increased significantly as the number of unfavorable genotypes in the pathway increased (P= .002). The final decision tree in the classification and regression tree analysis contained 5 terminal nodes. Compared with the never smokers (the lowest risk group), the odds ratios for terminal nodes 2 through 5 ranged from 1.21 to 5.40. CONCLUSIONS: The results illustrated the advantage of using a pathway-based approach for analyzing gene-gene and gene-smoking interactions. Specifically, the authors showed that genetic polymorphisms in cell-cycle control pathway genes may contribute to the risk of OPL.
BACKGROUND: Cell-cycle checkpoint controls regulate cell-cycle progression and proliferation. Alterations in cell-cycle control mechanisms are linked to tumorigenesis. METHODS: This case-control study included 147 cases and 147 controls. The authors used a pathway-based approach to assess the association between 10 potential functional single-nucleotide polymorphisms from 7 cell-cycle control genes and the risk of oral premalignant lesions (OPLs). They also used classification and regression tree analysis to examine high-order gene-gene and gene-smoking interactions. RESULTS: Compared with the homozygous wild-type GG genotype of CCND1P241P, individuals with the AG genotype exhibited an increased risk of OPL (odds ratio, 1.58; 95% confidence interval, 0.89-2.83), and carriers of the AA genotype had a significantly increased risk of OPL (odds ratio, 2.75; 95% confidence interval, 1.33-5.71), with risk increasing significantly with the increasing number of variant alleles (P= .006). The risk of OPL increased significantly as the number of unfavorable genotypes in the pathway increased (P= .002). The final decision tree in the classification and regression tree analysis contained 5 terminal nodes. Compared with the never smokers (the lowest risk group), the odds ratios for terminal nodes 2 through 5 ranged from 1.21 to 5.40. CONCLUSIONS: The results illustrated the advantage of using a pathway-based approach for analyzing gene-gene and gene-smoking interactions. Specifically, the authors showed that genetic polymorphisms in cell-cycle control pathway genes may contribute to the risk of OPL.
Authors: Maosheng Huang; Margaret R Spitz; Jian Gu; J Jack Lee; Jie Lin; Scott M Lippman; Xifeng Wu Journal: Carcinogenesis Date: 2006-04-25 Impact factor: 4.944
Authors: Xifeng Wu; Hua Zhao; Christopher I Amos; Sanjay Shete; Nimisha Makan; Waun K Hong; Fred F Kadlubar; Margaret R Spitz Journal: J Natl Cancer Inst Date: 2002-05-01 Impact factor: 13.506
Authors: Bina Raju; Ravi Mehrotra; Gunnvor Oijordsbakken; Ali K Al-Sharabi; Endre N Vasstrand; Salah O Ibrahim Journal: Anticancer Res Date: 2005 Nov-Dec Impact factor: 2.480
Authors: J J Lee; W K Hong; W N Hittelman; L Mao; R Lotan; D M Shin; S E Benner; X C Xu; J S Lee; V M Papadimitrakopoulou; C Geyer; C Perez; J W Martin; A K El-Naggar; S M Lippman Journal: Clin Cancer Res Date: 2000-05 Impact factor: 12.531
Authors: Xifeng Wu; Scott M Lippman; J Jack Lee; Yong Zhu; Q Victoria Wei; Margaret Thomas; Waun Ki Hong; Margaret R Spitz Journal: Cancer Res Date: 2002-05-15 Impact factor: 12.701